Reva Medical Files for IPO
Bruce V. Bigelow8/16/10
San Diego-based Reva Medical, which is developing bioabsorbable stents for treating arterial disease, has filed for a $63 million IPO on the Australian Stock Exchange, according to PE Hub. Inteq Ltd., a boutique investment bank in Sydney, is serving as the lead underwriter. The company has raised about $57 million in venture capital funding from Domain Partners, Cereberus Capital Managemet, Brookside Capital, and Group Outcome, according to PE Hub.
